Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

Table 1

Distribution of nonmalignant adnexal pathologies.

Pathology	Number of patients (%)
Endometriotic cyst	58 (22.30%)
Dermoid cyst	54 (20.76%)
Simple cyst	52 (20%)
Serous cystadenoma	46 (17.69%)
Mucinous cystadenoma	19 (7.30%)
Tuboovarian abscess/hydrosalpinx	16 (6.15%)
Paraductal cyst	9 (3.46%)
Ovarian fibroma	6 (2.30%)